The Haematology-Oncology Research Group (HORG) is a group at the National University Cancer Institute, Singapore (NCIS) that supports clinical trials for cancer treatments. HORG comprises of a dedicated team of clinical research coordinators, data coordinators, administrators, and finance executives.
It manages and supports all aspects of a clinical trial - from securing ethics, regulatory, budget, and legal approvals to the actual execution of the trial. From very early phase to late phase, HORG is one of few units in Asia capable of supporting a wide range of cancer drug trials including first-in-human trials.
